Schrödinger, Inc. (SDGR)
NASDAQ$22.78+0.85 (3.88%)
Market Cap
$1.6B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
831 of 924
Rank in Industry
35 of 40
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
SDGR Insider Trading Activity
SDGR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $367,140 | 8 | 100 |
Related Transactions
| Lorton Kenneth Patrick | EVP, CTO & COO, Software | 0 | $0 | 1 | $24,064 | $-24,064 |
| Dugan Margaret | Chief Medical Officer | 0 | $0 | 1 | $27,226 | $-27,226 |
| Abel Robert Lorne | See Remarks | 0 | $0 | 1 | $31,838 | $-31,838 |
| Herman Jenny | SVP & Controller | 0 | $0 | 2 | $35,045 | $-35,045 |
| Porges Geoffrey Craig | EVP & CFO | 0 | $0 | 1 | $119,484 | $-119,484 |
| Tran Yvonne | EVP, CLO & CPO | 0 | $0 | 2 | $129,484 | $-129,484 |
About Schrödinger, Inc.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. …
Insider Activity of Schrödinger, Inc.
Over the last 12 months, insiders at Schrödinger, Inc. have bought $0 and sold $367,140 worth of Schrödinger, Inc. stock.
On average, over the past 5 years, insiders at Schrödinger, Inc. have bought $111,386 and sold $348.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,115 shares for transaction amount of $111,386 was made by Lebowitz Joel (EVP & CFO) on 2021‑02‑05.
List of Insider Buy and Sell Transactions, Schrödinger, Inc.
| 2025-03-06 | Sale | Herman Jenny | SVP & Controller | 666 0.0009% | $21.11 | $14,059 | +2.90% | |
| 2025-03-03 | Sale | Porges Geoffrey Craig | EVP & CFO | 5,491 0.0077% | $21.76 | $119,484 | +0.61% | |
| 2025-02-18 | Sale | Tran Yvonne | EVP, CLO & CPO | 3,902 0.006% | $28.00 | $109,256 | -20.07% | |
| 2025-02-11 | Sale | Lorton Kenneth Patrick | EVP, CTO & COO, Software | 985 0.0013% | $24.43 | $24,064 | -10.45% | |
| 2025-02-11 | Sale | Herman Jenny | SVP & Controller | 859 0.0011% | $24.43 | $20,985 | -10.45% | |
| 2025-02-11 | Sale | Tran Yvonne | EVP, CLO & CPO | 828 0.0011% | $24.43 | $20,228 | -10.45% | |
| 2025-02-10 | Sale | Abel Robert Lorne | See Remarks | 1,225 0.0017% | $25.99 | $31,838 | -12.27% | |
| 2024-10-15 | Sale | Dugan Margaret | Chief Medical Officer | 1,531 0.002% | $17.78 | $27,226 | +19.38% | |
| 2024-03-04 | Sale | Porges Geoffrey Craig | EVP & CFO | 3,315 0.0048% | $26.35 | $87,360 | -15.45% | |
| 2024-02-12 | Sale | Lorton Kenneth Patrick | EVP, CTO & COO, Software | 901 0.0013% | $28.29 | $25,489 | -24.90% | |
| 2024-02-12 | Sale | Tran Yvonne | EVP, CLO & CPO | 758 0.0011% | $28.29 | $21,444 | -24.90% | |
| 2024-02-12 | Sale | Herman Jenny | SVP & Controller | 787 0.0011% | $28.29 | $22,264 | -24.90% | |
| 2024-02-12 | Sale | Abel Robert Lorne | See Remarks | 1,205 0.0016% | $27.55 | $33,198 | -24.90% | |
| 2023-08-09 | Sale | Lorton Kenneth Patrick | EVP & Chief Technology Officer | 10,000 0.0141% | $40.06 | $400,642 | -33.24% | |
| 2023-06-30 | Sale | Tran Yvonne | EVP, CLO & CPO | 12,040 0.0169% | $50.00 | $602,000 | -45.00% | |
| 2023-05-23 | Sale | Lorton Kenneth Patrick | EVP & Chief Technology Officer | 10,000 0.0146% | $40.06 | $400,587 | -21.37% | |
| 2023-05-23 | Sale | Tran Yvonne | EVP, CLO & CPO | 7,960 0.0116% | $40.01 | $318,461 | -21.37% | |
| 2023-05-22 | Sale | Tran Yvonne | EVP, CLO & CPO | 15,000 0.0189% | $35.04 | $525,632 | -22.04% | |
| 2023-05-22 | Sale | Thornberry Nancy | director | 14,850 0.0187% | $35.00 | $519,750 | -22.04% | |
| 2023-02-02 | Sale | Tran Yvonne | EVP & Chief Legal Officer | 25,000 0.0345% | $27.26 | $681,380 | +9.09% |
Total: 230
*Gray background shows transactions not older than one year
Insider Historical Profitability
61.14%
| BILL & MELINDA GATES FOUNDATION TRUST | 10 percent owner | 6981664 9.5589% | $153.11M | 1 | 3 | +110.06% |
| Flynn James E | 10 percent owner | 250000 0.3423% | $5.48M | 1 | 0 | +110.06% |
| Lebowitz Joel | EVP & CFO | 0 0% | $0 | 1 | 13 | <0.0001% |
SDGR Institutional Investors: Active Positions
| Increased Positions | 99 | +39.13% | 7M | +10.61% |
| Decreased Positions | 108 | -42.69% | 5M | -8% |
| New Positions | 33 | New | 633,513 | New |
| Sold Out Positions | 32 | Sold Out | 773,028 | Sold Out |
| Total Postitions | 244 | -3.56% | 64M | +2.61% |
SDGR Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $196,263.00 | 13.75% | 8.8M | +219,900 | +2.56% | 2024-12-31 |
| Gates Foundation Trust | $155,761.00 | 10.91% | 6.98M | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $147,522.00 | 10.33% | 6.61M | -95,127 | -1.42% | 2024-12-31 |
| Rubric Capital Management Lp | $111,550.00 | 7.81% | 5M | +1M | +35.67% | 2024-12-31 |
| Sumitomo Mitsui Trust Group, Inc. | $78,320.00 | 5.49% | 3.51M | +1M | +60.22% | 2024-12-31 |
| Nikko Asset Management Americas, Inc. | $54,992.00 | 3.85% | 2.46M | +1M | +108.72% | 2024-12-31 |
| State Street Corp | $51,683.00 | 3.62% | 2.32M | +160,981 | +7.47% | 2024-12-31 |
| Massachusetts Financial Services Co /Ma/ | $50,851.00 | 3.56% | 2.28M | +334,131 | +17.18% | 2024-12-31 |
| Ark Investment Management Llc | $49,277.00 | 3.45% | 2.21M | -127,710 | -5.47% | 2024-12-31 |
| Credit Suisse Ag/ | $44,362.00 | 3.11% | 1.99M | +180,398 | +9.98% | 2024-03-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.